Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells.
about
Oligodendrogenesis in the normal and pathological central nervous systemA defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosisRemyelination therapy for multiple sclerosisMultiple sclerosis-a quiet revolutionFingolimod: direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapySphingosine 1-phosphate signaling pathway in inner ear biology. New therapeutic strategies for hearing loss?Sphingosine 1-phosphate receptor agonists: a patent review (2010-2012)Overview and safety of fingolimod hydrochloride use in patients with multiple sclerosis.Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats.Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis.Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices.Innate inflammatory responses in stroke: mechanisms and potential therapeutic targets.Extracellular and intracellular actions of sphingosine-1-phosphateFingolimod for relapsing multiple sclerosis: an update.Evidence-based assessment of potential use of fingolimod in treatment of relapsing multiple sclerosis.Neurobiological effects of sphingosine 1-phosphate receptor modulation in the cuprizone model.Fingolimod modulates microglial activation to augment markers of remyelination.Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.Aberrant upregulation of astroglial ceramide potentiates oligodendrocyte injury.Recent advances in treating multiple sclerosis: efficacy, risks and place in therapy.Sphingolipids in cardiovascular and cerebrovascular systems: Pathological implications and potential therapeutic targets.Fingolimod modulates multiple neuroinflammatory markers in a mouse model of Alzheimer's disease.Cyclical and dose-dependent responses of adult human mature oligodendrocytes to fingolimod.FTY720 (fingolimod) for relapsing multiple sclerosis.Regulation and functions of sphingosine kinases in the brainDiffusion tensor imaging detects treatment effects of FTY720 in experimental autoimmune encephalomyelitis mice.Fingolimod and related compounds in a spontaneous autoimmune polyneuropathy.Roles for lysophospholipid S1P receptors in multiple sclerosis.Fingolimod for the treatment of relapsing multiple sclerosis.Fingolimod for multiple sclerosis: mechanism of action, clinical outcomes, and future directions.FTY720 on the way from the base camp to the summit of the mountain: relevance for remyelination.Lysophospholipid receptor activation of RhoA and lipid signaling pathways.Systematic review and meta-analysis of the efficacy of sphingosine-1-phosphate (S1P) receptor agonist FTY720 (fingolimod) in animal models of stroke.Molecular pharmacodynamics of new oral drugs used in the treatment of multiple sclerosisThe dual S1PR1/S1PR5 drug BAF312 (Siponimod) attenuates demyelination in organotypic slice cultures.Inflammatory responses in brain ischemia.Regulation of human glia by multiple sclerosis disease modifying therapies.Extracellular cues influencing oligodendrocyte differentiation and (re)myelinationEffect of Fingolimod on Neural Stem Cells: A Novel Mechanism and Broadened Application for Neural Repair.The sphingosine-1-phosphate receptor: A novel therapeutic target for multiple sclerosis and other autoimmune diseases.
P2860
Q21129352-A7405D1B-030D-4655-A8BB-0F4D39898FC0Q24644684-EF001B9A-A4B1-4D2C-AC5E-F2EBD3CDABF1Q26824246-8F83BB6A-BB5B-430E-99DB-3B8B2CCAC61FQ26826930-57E103CC-C2D6-47E5-8DC1-E5C41674BD2EQ27011473-18417AF8-E0A9-4244-97E6-B7CE4718BDD4Q27024207-C650369C-C1F0-4860-BAAD-C62452DBC77EQ28288034-6B14B352-1014-4AD7-8880-52776A048D4AQ30458371-05D2FFAB-24F5-45C8-83E9-C2B793F35F7FQ33611979-CECD2D56-5BCC-4244-9E57-242E76AB367EQ33881977-C0710501-04F1-426D-8B84-EE434BBDC1F6Q33882403-063D3204-5A12-4C35-A00E-01111C4879D6Q33925611-4B9125CF-64B3-4043-9386-48E3AC210F14Q34183703-E4356108-3272-4DA9-8F1D-31537F573A5EQ34618474-07D32460-ACAD-44F6-80A2-39E9DD5F6B72Q34729032-9706DEF9-01E4-4DE7-8888-DF83F7A8342FQ34813347-59315CF3-43D7-40AF-ADBA-8D7FC16B9233Q35154946-7DC6BE37-52D9-43C0-9043-EA22E2F58564Q35551835-C9EB0287-062D-4010-B458-031F4A749030Q35845455-AB96CE4E-D7DD-4051-9B71-A7AD2FC47AC2Q36515493-EFACFD4D-83F6-4989-842E-0EB0970EA055Q36840840-A2C64385-9741-483E-96D7-112C0233175EQ36841539-BF274250-3C1B-42CD-80E3-2D98F000E304Q36891556-A213A4FB-FE53-491D-B592-83282BD3EBF3Q37154788-FBD76065-D491-4D00-BBDF-E76A55895032Q37166130-01F34AEB-6481-435E-B1AD-3A3737BD5773Q37337129-25E3ABB5-9F9B-4A88-80C1-649A99CF185CQ37350365-C253FEB5-5ED3-4AC5-9360-5122EFB1CC3FQ37803419-83651A24-78B7-4B74-AA91-37D55CE10024Q37821010-DA0C88BB-9206-453A-B945-0822DE7345F7Q37905665-62013E85-91C6-4370-8E15-9E060825CED3Q37989903-988956AC-C766-49BA-A081-99C21A778B4FQ38044174-34A8748E-3AF9-4B54-B1BC-C2944ACB3D9DQ38061203-A8B43A22-EC5B-4B9C-8D3A-1487A3CC8B07Q38216015-B6B3197D-B0E3-43CB-961C-6464510F3BA9Q38303665-743713CB-22DD-4E71-B955-1A5D0875F856Q38349993-09EC9188-25C2-4208-B235-7E80711B93ADQ38563863-B5F8284B-4431-45D6-AA25-851DDEBD9EAAQ38789322-EC12748A-C3F5-4888-B5F7-63FB4979C7F7Q38983628-FE10BA9A-2C16-45C5-881E-69A04410444AQ39021621-DB4C6A41-534D-4E17-8CF3-A6652FB95BCD
P2860
Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells.
@en
Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells.
@nl
type
label
Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells.
@en
Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells.
@nl
prefLabel
Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells.
@en
Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells.
@nl
P2093
P50
P356
P1433
P1476
Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells
@en
P2093
P304
P356
10.1002/GLIA.20576
P577
2007-12-01T00:00:00Z